Highlights Essex Bio-Technology Limited

Equities

1061

KYG312371035

Market Closed - Hong Kong S.E. Other stock markets 04:08:06 2024-04-30 am EDT			5-day change	1st Jan Change
2.3 ^HKD	+2.68%		-0.86%	-7.63%

Mar. 18	Essex Bio-Technology Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 03	Essex Bio-Technology Limited Announces Change of Address of Head Office And principal Place of Business in Hong Kong	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Essex Bio-Technology's 2023 Profit Jumps 22% on Higher Turnover	Mar. 19	MT
Essex Bio-Technology Limited Proposes Final Ordinary Dividend for the Financial Year Ended 31 December 2023, Payable June 17, 2024	Mar. 18	CI
Essex Bio-Technology Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 18	CI
Essex Bio-Technology's Profit Jumps 22% in H1	23-08-17	MT
Essex Bio-Technology Limited Declares Interim Dividend for the Six Months Ended June 30, 2023, Payable on September 13, 2023	23-08-16	CI
Essex Bio-Technology Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-16	CI
Essex Bio-Technology Limited Provides Update on the Phase 1/2 Clinical Study in Relation to the Co-Development of the Licensed Product with Henlius for the Treatment of Exudative Age-Related Macular Degeneration	23-07-26	CI
Essex Bio-Technology Limited commences an Equity Buyback Plan for 57,064,900 shares, representing 10% of its issued share capital, under the authorization approved on June 9, 2023.	23-06-13	CI
Essex Bio-Technology Limited Declares Final Dividend for the Year Ended 31 December 2022	23-06-09	CI
Essex Bio-Technology Limited's Equity Buyback announced on May 12, 2022 has expired.	23-06-08	CI
Essex Bio-Technology Slashes Final Dividend as 2022 Profit Falls	23-03-09	MT
Essex Bio-Technology Limited Declares Final Dividend for the Year Ended 31 December 2022, Payable on 29 June 2023	23-03-08	CI
Tranche Update on Essex Bio-Technology Limited's Equity Buyback Plan announced on May 12, 2022.	23-03-08	CI
Essex Bio-Technology Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-08	CI
Essex Bio-Technology Limited Completes First Patient First Dose in the United States in an International Multi-Centre Phase 3 Clinical Study	23-02-10	CI
Essex Bio-Technology Expects 35% Fall in 2022 Profit; Shares Slip 3%	23-01-10	MT
Essex Bio-Technology Limited Provides Preliminary Unaudited Consolidated Group Earnings Guidance for the Year Ended 31 December 2022	23-01-10	CI
Essex Bio-Technology Limited Declares Interim Dividend for the Six Months Ended 30 June 2022, Payable on September 21, 2022	22-08-23	CI
Tranche Update on Essex Bio-Technology Limited's Equity Buyback Plan announced on May 12, 2022.	22-08-23	CI
Essex Bio-Technology Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Essex Bio-Technology Limited

Equities

1061

KYG312371035

Highlights

Filters